BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18338772)

  • 1. How important is mesalamine in the maintenance of steroid-refractory colitis?
    Actis GC; Marzano A; Pellicano R; Rizzetto M
    Inflamm Bowel Dis; 2008 Jul; 14(7):1026. PubMed ID: 18338772
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T; Umegae S; Matsumoto K
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of myocarditis after mesalazine treatment for ulcerative colitis: a case report.
    Sabatini T; Filippini A; Nicosia F; Preti S; Bertoli M
    Inflamm Bowel Dis; 2013 Mar; 19(3):E46-8. PubMed ID: 22517473
    [No Abstract]   [Full Text] [Related]  

  • 5. Once-daily mesalamine (Lialda) for ulcerative colitis.
    Med Lett Drugs Ther; 2007 Mar; 49(1257):25-6. PubMed ID: 17375030
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesalamine in the Initial Therapy of Ulcerative Colitis.
    Chibbar R; Moss AC
    Gastroenterol Clin North Am; 2020 Dec; 49(4):689-704. PubMed ID: 33121689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].
    Inatsuchi S; Nakajima T; Yoshio Y; Entani A; Okada K
    Nihon Shokakibyo Gakkai Zasshi; 2004 Sep; 101(9):989-92. PubMed ID: 15478662
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
    Bello C; Belaiche J; Louis E; Reenaers C
    J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
    Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?].
    Folwaczny C
    Z Gastroenterol; 2000 Jun; 38(6):547-50. PubMed ID: 10923365
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesalamine in the treatment and maintenance of remission of ulcerative colitis.
    Ham M; Moss AC
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):113-23. PubMed ID: 22390554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis treatment for children and teens.
    FDA Consum; 2007; 41(2):5. PubMed ID: 17582854
    [No Abstract]   [Full Text] [Related]  

  • 16. Once-daily mesalamine granules for ulcerative colitis.
    Lawlor G; Ahmed A; Moss AC
    Expert Rev Clin Immunol; 2010 Jul; 6(4):521-6. PubMed ID: 20594123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.
    García-Morán S; Sáez-Royuela F; Pérez-Alvarez JC; Gento E; Téllez J
    Inflamm Bowel Dis; 2006 Apr; 12(4):334-5. PubMed ID: 16633055
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.